Astec Lifesciences Shareholding

Astec Lifesciences Ltd Shareholding Pattern

The Astec Lifesciences Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Astec Lifesciences Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Astec Lifesciences Ltd (NSE: ASTEC, BSE: 533138) operates in the Process industries sector and Chemicals: agricultural industry. Monitoring the Astec Lifesciences Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Astec Lifesciences Ltd Shareholding Pattern (Latest)

The latest Astec Lifesciences Ltd shareholding for Dec 2025 is:

• Promoters: 71.97%
• FII: 0.04%
• DII: 3.17%
• Public: 24.82%
• Government: 0%

A slight decline in promoter holding may indicate stake dilution or strategic selling.

Astec Lifesciences Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Astec Lifesciences Ltd.

• Dec 2025: 71.97%
• Sept 2025: 72.42%
• Jun 2025: 70.87%
• Mar 2025: 70.87%
• Dec 2024: 66.75%

Promoter stake remains largely stable, showing consistent ownership structure.

Astec Lifesciences Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Astec Lifesciences Ltd.

• Dec 2025: 0.04%
• Sept 2025: 0.00%
• Jun 2025: 0.02%
• Mar 2025: 0.25%
• Dec 2024: 1.20%

FII holding in Astec Lifesciences Ltd has increased recently, indicating rising foreign investor interest.

Astec Lifesciences Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Dec 2025: 3.17%
• Sept 2025: 4.01%
• Jun 2025: 4.26%
• Mar 2025: 4.34%
• Dec 2024: 5.41%

DII holdings remain stable, reflecting steady institutional participation.

Astec Lifesciences Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Dec 2025: 24.82%
• Sept 2025: 23.57%
• Jun 2025: 24.84%
• Mar 2025: 24.54%
• Dec 2024: 26.64%

Public participation in Astec Lifesciences Ltd has increased, indicating rising retail investor interest.

Astec Lifesciences Ltd Government Holding

Government holding in Astec Lifesciences Ltd currently stands at 0%.

Astec Lifesciences Ltd operates without significant government ownership.

Astec Lifesciences Ltd Shareholding Analysis Summary

The Astec Lifesciences Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Astec Lifesciences Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.

Regular monitoring of the Astec Lifesciences Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.